159 related articles for article (PubMed ID: 27467915)
1. Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell response.
Cappello P; Tonoli E; Curto R; Giordano D; Giovarelli M; Novelli F
Oncoimmunology; 2016 May; 5(5):e1112940. PubMed ID: 27467915
[TBL] [Abstract][Full Text] [Related]
2. PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer.
Curcio C; Mucciolo G; Roux C; Brugiapaglia S; Scagliotti A; Guadagnin G; Conti L; Longo D; Grosso D; Papotti MG; Hirsch E; Cappello P; Varner JA; Novelli F
J Exp Clin Cancer Res; 2024 Jun; 43(1):157. PubMed ID: 38824552
[TBL] [Abstract][Full Text] [Related]
3. Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners.
Cappello P; Curcio C; Mandili G; Roux C; Bulfamante S; Novelli F
Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29462900
[TBL] [Abstract][Full Text] [Related]
4. Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis.
Principe M; Borgoni S; Cascione M; Chattaragada MS; Ferri-Borgogno S; Capello M; Bulfamante S; Chapelle J; Di Modugno F; Defilippi P; Nisticò P; Cappello P; Riganti C; Leporatti S; Novelli F
J Hematol Oncol; 2017 Jan; 10(1):16. PubMed ID: 28086938
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer.
Cappello P; Rolla S; Chiarle R; Principe M; Cavallo F; Perconti G; Feo S; Giovarelli M; Novelli F
Gastroenterology; 2013 May; 144(5):1098-106. PubMed ID: 23333712
[TBL] [Abstract][Full Text] [Related]
6. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F
Oncotarget; 2015 May; 6(13):11098-113. PubMed ID: 25860938
[TBL] [Abstract][Full Text] [Related]
7. Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival.
Curcio C; Rosso T; Brugiapaglia S; Guadagnin G; Giordano D; Castellino B; Satolli MA; Spadi R; Campra D; Moro F; Papotti MG; Bertero L; Cassoni P; De Angelis C; Langella S; Ferrero A; Armentano S; Bellotti G; Fenocchio E; Nuzzo A; Ciccone G; Novelli F
Clin Exp Med; 2023 Dec; 23(8):5089-5100. PubMed ID: 37910256
[TBL] [Abstract][Full Text] [Related]
8. In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination.
Mandili G; Curcio C; Bulfamante S; Follia L; Ferrero G; Mazza E; Principe M; Cordero F; Satolli MA; Spadi R; Evangelista A; Giordano D; Viet D; Cappello P; Novelli F
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33115943
[TBL] [Abstract][Full Text] [Related]
9. Alpha-enolase (ENO1), identified as an antigen to monoclonal antibody 12C7, promotes the self-renewal and malignant phenotype of lung cancer stem cells by AMPK/mTOR pathway.
Shu X; Cao KY; Liu HQ; Yu L; Sun LX; Yang ZH; Wu CA; Ran YL
Stem Cell Res Ther; 2021 Feb; 12(1):119. PubMed ID: 33579362
[TBL] [Abstract][Full Text] [Related]
10. Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma.
Niccolai E; Cappello P; Taddei A; Ricci F; D'Elios MM; Benagiano M; Bechi P; Bencini L; Ringressi MN; Coratti A; Cianchi F; Bonello L; Di Celle PF; Prisco D; Novelli F; Amedei A
Int J Oncol; 2016 Jul; 49(1):393-401. PubMed ID: 27210467
[TBL] [Abstract][Full Text] [Related]
11. A Novel Enolase-1 Antibody Targets Multiple Interacting Players in the Tumor Microenvironment of Advanced Prostate Cancer.
Chen ML; Yuan TT; Chuang CF; Huang YT; Chung IC; Huang WC
Mol Cancer Ther; 2022 Aug; 21(8):1337-1347. PubMed ID: 35700013
[TBL] [Abstract][Full Text] [Related]
12. Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation.
Bian Z; Abdelaal AM; Shi L; Liang H; Xiong L; Kidder K; Venkataramani M; Culpepper C; Zen K; Liu Y
Eur J Immunol; 2018 Jun; 48(6):1046-1058. PubMed ID: 29488625
[TBL] [Abstract][Full Text] [Related]
13. Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
Baert T; Vankerckhoven A; Riva M; Van Hoylandt A; Thirion G; Holger G; Mathivet T; Vergote I; Coosemans A
Front Immunol; 2019; 10():1273. PubMed ID: 31214202
[TBL] [Abstract][Full Text] [Related]
14. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of IL-18-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy against osteosarcoma cancer.
Guan Y; Zhang R; Peng Z; Dong D; Wei G; Wang Y
J Bone Oncol; 2017 Nov; 9():59-64. PubMed ID: 29226090
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression.
Tsukamoto H; Nishikata R; Senju S; Nishimura Y
Cancer Immunol Res; 2013 Jul; 1(1):64-76. PubMed ID: 24777249
[TBL] [Abstract][Full Text] [Related]
17. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
18. T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy.
Raber PL; Sierra RA; Thevenot PT; Shuzhong Z; Wyczechowska DD; Kumai T; Celis E; Rodriguez PC
Oncotarget; 2016 Apr; 7(14):17565-78. PubMed ID: 27007050
[TBL] [Abstract][Full Text] [Related]
19. Anti α-enolase antibody is a novel autoimmune biomarker for unexplained recurrent miscarriages.
Ye Y; Kuhn C; Kösters M; Arnold GJ; Ishikawa-Ankerhold H; Schulz C; Rogenhofer N; Thaler CJ; Mahner S; Fröhlich T; Jeschke U; von Schönfeldt V
EBioMedicine; 2019 Mar; 41():610-622. PubMed ID: 30827932
[TBL] [Abstract][Full Text] [Related]
20. The immunoregulatory role of alpha enolase in dendritic cell function during Chlamydia infection.
Ryans K; Omosun Y; McKeithen DN; Simoneaux T; Mills CC; Bowen N; Eko FO; Black CM; Igietseme JU; He Q
BMC Immunol; 2017 May; 18(1):27. PubMed ID: 28525970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
